The mineralization assay showed that mineralized matrix nodules were readily detected in the BMP9-treated group on Day 14 after infection, and the mineralized nodules in the BMP9 combined with SMOC2-treated group were slightly increased compared with those in the group treated with BMP9 only. This evidence concerns the gene SMOC2 and infection.